Athersys (ATHX)
Athersys Price / Book Value: 4.313
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ATHX Price / Book Value Rankings
| Overall | 12th percentile | 3717 of 4243 |
| Sector | 30th percentile | 330 of 474 in Healthcare |
| Industry | 44th percentile | 79 of 143 in Biotechnology |
ATHX Price / Book Value Range, Past 5 Years
| Minimum | 0.2699 | Dec 2008 |
| Maximum | 5.805 | Dec 2011 |
| Average | 3.061 |
About Price to Book Ratio
The price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.
The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.
In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.
Learn More
You may also be interested in these ATHX related companies
ATHX News
$ARNA $KERX $ATHX cnbc: Greeks repaying $430b due today, to Hedge Funds! wow. that money will be back in US stocks.
about 12 days ago by milroyt
about 12 days ago by milroyt
$ARNA $KERX $ATHX don't forget, Europe's still open and moved up but they're selling what they can get money in. Eur closes: it's better.
about 12 days ago by milroyt
about 12 days ago by milroyt
$KERX $ARNA $ATHX looks like a nice beginning to the day setting up ... good luck to us all!
about 13 days ago by milroyt
about 13 days ago by milroyt
$ATHX earnings out today...? no news anywhere other than that. pls post if you see or know when they announce....
about 13 days ago by milroyt
about 13 days ago by milroyt
EBR: Watchlist/worksheet/4 Trading Ideas: That was $CYTX not $ATHX
about 17 days ago by TheEquitiesRoom
about 17 days ago by TheEquitiesRoom
@selectstock on AMT i saw it 1.44 +.19, showing b/a now 1.50-1.54 on $ATHX. i saw early a.m. mention, dont know the stk. thx for info
about 17 days ago by milroyt
about 17 days ago by milroyt
$ATHX is it a happy sympathy play that $ATHX moved up late on anticipating ++ $ARNA vote?
about 17 days ago by milroyt
about 17 days ago by milroyt
$ATHX moving higher. Does this forshadow positive news for $ARNA? Both companies use same receptor that lorcaserin uses
about 17 days ago by stockeye
about 17 days ago by stockeye
$ATHX forms bearish "Top Triangle" chart pattern. http://stks.co/3JPm
about 46 days ago by RecogniaEvents
about 46 days ago by RecogniaEvents
Athersys (ATHX) Gets U.S. Patent for non-Embryonic Stem Cell Use in Reducing GvHD
Apr 04, 7:03AM Street Insider
Apr 04, 7:03AM Street Insider
$ATHX forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/36jt
about 61 days ago by RecogniaEvents
about 61 days ago by RecogniaEvents
$ATHX forms bearish "Continuation Diamond" chart pattern. http://stks.co/2lrk
about 79 days ago by RecogniaEvents
about 79 days ago by RecogniaEvents
Athersys to Host Fourth Quarter and Year-End 2011 Financial Results Call
Mar 09, 12:00PM GlobeNewswire
Mar 09, 12:00PM GlobeNewswire
Athersys (ATHX) Reports Positve Data from MultiStem Phase I in HSCT Patients
Feb 01, 3:01PM Street Insider
Feb 01, 3:01PM Street Insider
Athersys Awarded $3.6 Million in Grant Funding for Stem Cell Product Development
Feb 01, 7:09AM Benzinga
Feb 01, 7:09AM Benzinga
Athersys Receives U.S. Patent Covering the Treatment of Cardiovascular Disease With Adult Stem Cells
Jan 04, 7:00AM GlobeNewswire
Jan 04, 7:00AM GlobeNewswire
Athersys to Present at 23rd Annual Piper Jaffray Health Care Conference
Nov 23, 11:00AM GlobeNewswire
Nov 23, 11:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATHX | 1.40 | -0.02 | -1.41% | 34.58M |
| ATHN | 76.34 | -1.50 | -1.93% | 2.707B |
| ATEC | 1.65 | +0.01 | +0.61% | 147.82M |
| ASUR | 4.98 | +0.02 | +0.40% | 23.06M |
| ASTX | 1.81 | +0.06 | +3.43% | 168.46M |
| ASTMD | 2.05 | -0.01 | -0.49% | |
| ASTM | 2.05 | -0.01 | -0.49% | 79.46M |
| ASTI | 0.5391 | -0.02 | -3.73% | 22.08M |
| ASTE | 28.39 | -0.11 | -0.39% | 644.74M |
| BBOX | 22.22 | +0.19 | +0.86% | 388.41M |
